Evidence map›Paper›PMID 41303785›Full record

ArticleMedicina (Kaunas, Lithuania)2025

The Association and Significance of MDM2 and NF-κB Protein Expression in Multiple Myeloma.

Marija Stanić Damić, Aron Grubešić, Zinaida Perić, Nives Jonjić, Irena Seili-Bekafigo, Goran Hauser, Nina Jajaš, Toni Valković

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Uncovering Time-DependentMolecules (Basel, Switzerland) · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Marija Stanić DamićDepartment of Internal Medicine, Division of Hematology, Clinical Hospital Center Rijeka, Krešimirova 42, 51000 Rijeka, Croatia.ORCID 0000-0002-0456-0350
Aron GrubešićDepartment of Internal Medicine, Division of Hematology, Clinical Hospital Center Rijeka, Krešimirova 42, 51000 Rijeka, Croatia.ORCID 0000-0002-8522-9693
Zinaida PerićDepartment of Internal Medicine, Division of Hematology, Clinical Hospital Center Rijeka, Krešimirova 42, 51000 Rijeka, Croatia.
Nives JonjićFaculty of Medicine, University of Rijeka, 51000 Rijeka, Croatia.
Irena Seili-BekafigoFaculty of Medicine, University of Rijeka, 51000 Rijeka, Croatia.ORCID 0000-0001-5285-1497
Goran HauserDepartment of Internal Medicine, Division of Hematology, Clinical Hospital Center Rijeka, Krešimirova 42, 51000 Rijeka, Croatia.ORCID 0000-0002-4758-1717
Nina JajašDepartment of Internal Medicine, Division of Hematology, Clinical Hospital Center Rijeka, Krešimirova 42, 51000 Rijeka, Croatia.
Toni ValkovićFaculty of Health Studies, University of Rijeka, 51000 Rijeka, Croatia.ORCID 0000-0003-2117-9030

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Multiple MyelomaNF-kappa BProto-Oncogene Proteins c-mdm2AgedAged, 80 and overAntineoplastic AgentsBone MarrowBortezomibFemaleHumansImmunohistochemistryMaleMiddle AgedPilot ProjectsPrognosisAntineoplastic AgentsBortezomibMDM2 protein, humanNF-kappa BProto-Oncogene Proteins c-mdm2biomarkerbortezomibMDM2multiple myelomaNF-κBprotein expressionrenal impairment

Identifiers

PMID41303785
PMCPMC12654194

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.